Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Nec Oncoimmunity AS
AS
Active
Org 913062612
Ullernchausséen 64, 0379
Oslo
Computer programming activities
·
NACE 6210
Est. 2014 · 12 years old
33 employees
Monitor
Share
Norway
/
Companies
/
Computer programming activities
/
Nec Oncoimmunity AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
SN
Saverio Niccolini
Chief Executive Officer
Chief Executive Officer
2024
Former (2)
AK
Akira Kitamura
Chief Executive Officer
Chief Executive Officer
2024 – 2024
RN
Richard Nicholas John Stratford
Chief Executive Officer
Chief Executive Officer
2016 – 2024
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
SN
Saverio Niccolini
Chairman
Chairman
2026
Former (8)
AK
Akira Kitamura
Chairman
Chairman
2021 – 2026
TC
Trevor Clancy
Board of Directors
Board of Directors
2021 – 2024
JW
Jürgen Wilhelm Quittek
Board of Directors
Board of Directors
2021 – 2026
TK
Tomoki Kubo
Board of Directors
Board of Directors
2019 – 2021
RN
Richard Nicholas John Stratford
Board of Directors
Board of Directors
2021 – 2024
NY
Naoko Yamagata
Board of Directors
Board of Directors
2021 – 2026
TT
Tomoyuki Takaoka
Board of Directors
Board of Directors
2024 – 2026
AB
Angelo Binetti
Board of Directors
Board of Directors
2024 – 2026
Shareholders
As of last annual report
Nec Bio Bv — 100%
100%
Shareholder
Type
Ownership
Votes
Since
Nec Bio Bv
Company
100%
100%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Nec Oncoimmunity AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network